Literature DB >> 18728523

HLA-DQB1*02 dose effect on RIA anti-tissue transglutaminase autoantibody levels and clinicopathological expressivity of celiac disease.

Raffaella Nenna1, Barbara Mora, Francesca Megiorni, Maria Cristina Mazzilli, Fabio Massimo Magliocca, Claudio Tiberti, Margherita Bonamico.   

Abstract

OBJECTIVES: Celiac disease is an autoimmune enteropathy caused by gluten ingestion in genetically susceptible individuals. Anti-transglutaminase autoantibody (tTGAb) assay is useful to detect candidates undergoing intestinal biopsy. Our aim was to investigate whether the DQB1*02 allele could influence tTGAb titers and the clinicopathological expressivity of the disease.
METHODS: A total of 124 patients with celiac disease, tested for RIA tTGAb at diagnosis, were typed for HLA-DRB1, -DQA1, and -DQB1 genes and divided according to the number of DQB1*02 alleles: group 1, homozygous; group 2, heterozygous; group 3, negative.
RESULTS: The mean of tTGAb indexes was significantly higher in group 1 patients than in group 2 (P < 0.02) and group 3 patients (P < 0.01). Patients with at least 1 DQB1*02 allele showed more often a typical CD and diffuse histological lesions than did patients in the other groups.
CONCLUSIONS: The study demonstrates that tTGAb titers are HLA-DQB1*02 dose dependent, with significantly higher levels in homozygous individuals. Moreover, individuals with at least 1 HLA-DQB1*02 allele tend to have a more expressed clinical and histological form of celiac disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728523     DOI: 10.1097/MPG.0b013e3181615ca7

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  HLA-DQ genetics in children with celiac disease: a meta-analysis suggesting a two-step genetic screening procedure starting with HLA-DQ β chains.

Authors:  Annalisa De Silvestri; Cristina Capittini; Dimitri Poddighe; Chiara Valsecchi; Gianluigi Marseglia; Sara Carlotta Tagliacarne; Valeria Scotti; Chiara Rebuffi; Annamaria Pasi; Miryam Martinetti; Carmine Tinelli
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

2.  Children with celiac disease and high tTGA are genetically and phenotypically different.

Authors:  Amani Mubarak; Eric Spierings; Victorien M Wolters; Henny G Otten; Fiebo J W ten Kate; Roderick H J Houwen
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

3.  Celiac disease in pediatric patients according to HLA genetic risk classes: a retrospective observational study.

Authors:  Carlo Tolone; Marisa Piccirillo; Pasquale Dolce; Salvatore Alfiero; Mattia Arenella; Marina Sarnataro; Patrizia Iardino; Alessia Pucciarelli; Caterina Strisciuglio
Journal:  Ital J Pediatr       Date:  2021-05-05       Impact factor: 2.638

4.  Classical celiac disease is more frequent with a double dose of HLA-DQB1*02: A systematic review with meta-analysis.

Authors:  Judit Bajor; Zsolt Szakács; Nelli Farkas; Péter Hegyi; Anita Illés; Margit Solymár; Erika Pétervári; Márta Balaskó; Gabriella Pár; Patrícia Sarlós; Ákos Szűcs; József Czimmer; Kata Szemes; Orsolya Huszár; Péter Varjú; Áron Vincze
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

5.  Influence of HLA on clinical and analytical features of pediatric celiac disease.

Authors:  Eva Martínez-Ojinaga; Marta Fernández-Prieto; Manuel Molina; Isabel Polanco; Elena Urcelay; Concepción Núñez
Journal:  BMC Gastroenterol       Date:  2019-06-13       Impact factor: 3.067

Review 6.  Salivary Microbiome in Pediatric and Adult Celiac Disease.

Authors:  Dimitri Poddighe; Almagul Kushugulova
Journal:  Front Cell Infect Microbiol       Date:  2021-02-17       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.